A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes

NCT03298542 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Pre-Symptomatic Type 1 Diabetes

Interventions

DRUG: Golimumab
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC